IPO Boutique

Scholar Rock Holding Corporation IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Scholar Rock Holding Corporation , and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Scholar Rock Holding Corporation SRRK -
NASDAQ
$13.00-$15.00 $14.00 $14.255.4 million5/24/2018
Jefferies, Cowen, BMO Capital
Co-Manager(s):
Wedbush PacGrow
Health Care
Filing(s):

Filed 2018-04-27
Terms Added 2018-05-14
Final Prospectus 2018-05-24



Scholar Rock Holding Corporation Quote & Chart - Click for current quote - SRRK

About Scholar Rock Holding Corporation (adapted from Scholar Rock Holding Corporation prospectus):
They are a biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "SRRK" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved